Plas-Tech Engineering made its debut at CPHI Milan as part of H&T Presspart, with the event taking place from 6–8 October 2026 at Fiera Milano. Bringing together pharmaceutical and healthcare professionals from across the globe, CPHI Milan provided an excellent opportunity for us to meet a wider industry audience, showcase our drug-delivery solutions and connect with existing and prospective customers.
This year marked an important milestone for Plas-Tech Engineering as our first CPHI appearance as part of H&T Presspart. Joining the wider H&T Presspart team enabled us to showcase our capabilities alongside a comprehensive portfolio of drug-delivery technologies, while demonstrating how Plas-Tech’s expertise complements H&T Presspart’s growing drug delivery device and services offering.
A key focus at the event was our Equinox® range of pre-fillable syringes. Developed as a glass-replacement solution for pharmaceutical and biological drug delivery, the Equinox® range reflects our focus on providing innovative solutions for the evolving requirements of modern drug delivery.
The range offers an opportunity to explore alternatives to traditional glass syringes, supporting pharmaceutical and biologic drug developers as they consider the requirements of increasingly complex therapies and delivery systems. Alongside Equinox®, the H&T Presspart stand featured a broad range of drug-delivery solutions spanning both parenteral and inhalation applications.
Within the parenteral portfolio, visitors were introduced to Vylo™ cartridge seals, offering reliable cartridge sealing for pharmaceutical and healthcare applications, as well as Vytal®, a ready-to-use (RTU) snap-fit vial closure designed to meet the requirements of advanced therapeutics and modern aseptic filling processes.
For Plas-Tech, being able to present Equinox® alongside these complementary technologies demonstrated the breadth of the combined offering and the opportunities created through our integration with H&T Presspart.
The stand also showcased H&T Presspart’s established inhalation portfolio, including MDI canisters, actuators, dose counters and Sunriser® DPI technology. A particular focus was placed on supporting the industry’s transition towards lower-carbon metered-dose inhalers, including next-generation PFAS-free surface treatment technologies and analytical services to help customers evaluate and transition to lower-carbon propellants.Connecting with customers and industry partners
As part of H&T Presspart, Plas-Tech can now draw on a broader range of capabilities and expertise across drug-delivery development and manufacturing. Together, the combined offering supports customers across the development journey, from initial concepts and prototyping through to industrialisation and manufacturing.Looking ahead
Our first CPHI Milan as part of H&T Presspart was an important milestone for Plas-Tech Engineering. The event gave us the opportunity to introduce Equinox® to a wider audience, showcase our capabilities as part of the H&T Presspart portfolio and strengthen relationships across the pharmaceutical and drug-delivery industries.
We would like to thank everyone who visited the stand and took the time to meet with our team. We look forward to continuing these conversations, developing new opportunities and working with our customers and partners to advance the next generation of drug-delivery solutions.
We look forward to seeing you next year in Frankfurt.
